Trial Profile
A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Alcaftadine (Primary) ; Olopatadine
- Indications Allergic conjunctivitis
- Focus Therapeutic Use
- Sponsors Allergan
- 01 Sep 2015 New trial record